GlassScriptPhysician profile
Alyssa Dweck
NPI 1104872811
$37,776.36
in general payments reported to CMS, 2019-2025
9 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $2,085 · 2021: $2,303 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $313.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $20,541.11 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $13,933.04 | 2019 | |
| Agile Therapeutics, INC. | $2,302.50 | 2021 | |
| Exeltis, USA INC. | $686.20 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $133.36 | 2025 | |
| Astellas Pharma US INC | $85.27 | 2025 | Veozah |
| Xeris Pharmaceuticals, INC. | $59.35 | 2025 | Recorlev |
| Lilly USA, LLC | $21.33 | 2025 | Mounjaro, Zepbound |
| Ascendis Pharma Endocrinology INC | $14.20 | 2025 | Yorvipath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Dweck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.